Gene Transfer of COX-1 Improves Lumen Size and Blood Flow in Carotid Bypass Grafts1

Journal of Surgical Research

Volumn 161, Issue 1, 2010, Pages 162-167

  Eichstaedt, Harald C ^a   Liu, Qi ^a   Chen, Zhiqiang ^a,b   Bobustuc, George C ^a   Terry, Toya ^a   Willerson, James T ^a,b   Zoldhelyi, Pierre ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

arterial vein grafts; atherosclerosis; cyclooxygenase; prostaglandins, gene therapy; restenosis

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC AMP; CYCLOOXYGENASE 1; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CAROTID ARTERY; CAROTID ARTERY FLOW; CAROTID ARTERY SURGERY; CHOLESTEROL DIET; CONTROLLED STUDY; EX VIVO STUDY; GENE OVEREXPRESSION; GENE TRANSFER; HYPERCHOLESTEROLEMIA; INCUBATION TIME; JUGULAR VEIN; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASODILATATION; VEIN GRAFT;

ANIMALS; CHOLESTEROL; CYCLIC AMP; CYCLOOXYGENASE 1; EPOPROSTENOL; GENE THERAPY; HYPERCHOLESTEROLEMIA; JUGULAR VEINS; RABBITS; REGIONAL BLOOD FLOW; VASODILATION;

EID: 77951621737     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.012     Document Type: Article

References (35)

1. Fitzgibbon G.M., Kafka H.P., Leach A.J., et al. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616
2. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916
3. Cross K.S., el-Sanadiki M.N., Murray J.J., et al. Functional abnormalities of experimental autogenous vein graft neoendothelium. Ann Surg 208 (1988) 631
4. Schwartz L.B., O'Donohoe M.K., Purut C.M., et al. Myointimal thickening in experimental vein grafts is dependent on wall tension. J Vasc Surg 15 (1992) 176
5. Westerband A., Crouse D., Richter L.C., et al. Vein adaptation to arterialization in an experimental model. J Vasc Surg 33 (2001) 561
6. Faries P.L., Marin M.L., Veith F.J., et al. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg 24 (1996) 463
7. Ku D.D., Caulfield J.B., and Kirklin J.K. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation 83 (1991) 402
8. Newby A.C. Molecular and cell biology of native coronary and vein-graft atherosclerosis: regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions. Coron Artery Dis 8 (1997) 213
9. Stark V.K., Hoch J.R., Warner T.F., et al. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 17 (1997) 1614
10. Sterpetti A.V., Cucina A., Lepidi S., et al. Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery 123 (1998) 461
11. Belton O., Byrne D., Kearney D., et al. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102 (2000) 840
12. Crutchley D.J., Conanan L.B., and Que B.G. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells. J Pharmacol Exp Ther 271 (1994) 446
13. Kowala M.C., Mazzucco C.E., Hartl K.S., et al. Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production. Arterioscler Thromb 13 (1993) 435
14. Uehara Y., Ishimitsu T., Kimura K., et al. Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins 36 (1988) 847
15. Hara S., Morishita R., Tone Y., et al. Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem Biophys Res Commun 216 (1995) 862
16. Wu K.K. Regulation of prostaglandin H synthase-1 gene expression. Adv Exp Med Biol 400A (1997) 121
17. Zoldhelyi P., McNatt J., Xu X.M., et al. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation 93 (1996) 10
18. Davies M.G., Huynh T.T., Fulton G.J., et al. G protein signaling and vein graft intimal hyperplasia: reduction of intimal hyperplasia in vein grafts by a Gbetagamma inhibitor suggests a major role of G protein signaling in lesion development. Arterioscler Thromb Vasc Biol 18 (1998) 1275
19. Mann M.J., Gibbons G.H., Kernoff R.S., et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A 92 (1995) 4502
20. Harada M., Toki Y., Numaguchi Y., et al. Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications. Cardiovasc Res 43 (1999) 481
21. Liu Q., Chen Z.Q., Bobustuc G.C., et al. Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteries. Circulation 111 (2005) 1833
22. Todaka T., Yokoyama C., Yanamoto H., et al. Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke 30 (1999) 419
23. Batellier J., Wassef M., Merval R., et al. Protection from atherosclerosis in vein grafts by a rigid external support. Arterioscler Thromb 13 (1993) 379
24. Klyachkin M.L., Davies M.G., Svendsen E., et al. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function. J Surg Res 54 (1993) 451
25. Zwolak R.M., Kirkman T.R., and Clowes A.W. Atherosclerosis in rabbit vein grafts. Arteriosclerosis 9 (1989) 374
26. Schwartz L.B., Moawad J., Svensson E.C., et al. Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts. J Vasc Surg 29 (1999) 874
27. Zoldhelyi P., Chen Z.Q., Shelat H.S., et al. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A 98 (2001) 4078
28. Indolfi C., Di Lorenzo E., Rapacciuolo A., et al. 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J Am Coll Cardiol 36 (2000) 288
29. Tanner F.C., Meier P., Greutert H., et al. Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101 (2000) 1982
30. Zoldhelyi P., Chen Z.-Q., Shelat H.S., et al. Adenoviral gene transfer of cyclooxygenase-1 improves luminal area and blood flow after carotid balloon injury in atherosclerotic Watanabe rabbits (Abstract). J Am Coll Cardiol 35 Suppl A (2000)
31. Folts J.D., Gallagher K., and Rowe G.G. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?. Circulation 65 (1982) 248
32. Jiang Z., Wu L., Miller B.L., et al. A novel vein graft model: adaptation to differential flow environments. Am J Physiol Heart Circ Physiol 286 (2004) H240
33. Nguyen K.T., Frye S.R., Eskin S.G., et al. Cyclic strain increases protease-activated receptor-1 expression in vascular smooth muscle cells. Hypertension 38 (2001) 1038
34. Okon E.B., Chung A.W.Y., Hsiang Y.N., et al. Cellular mechanisms of bypass vein graft arterialization and approaches to attenuate graft remodeling. Vasc Dis Prev 5 (2008) 33
35. Shyue S.K., Tsai M.J., Liou J.Y., et al. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation 103 (2001) 2090